|
 |
aztreonamThis page contains recent news articles, when available, and an overview of aztreonam but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.O) aztreonam was an effective new treatment for life-threatening lung infections in cystic fibrosis patients. The drug won marketing approval in September ... Reuters Setback for Gilead's Pipeline - Dec 28, 2009 Approval of aztreonam will strengthen Gilead's non HIV portfolio. Earnings over the past few quarters have been above expectations specifically on strong ... Zacks.com FDA Advisory Committee Supports Use Of Aztreonam For Inhalation Solution For ... - Dec 13, 2009 The committee voted 15 to 2 that Gilead has provided sufficient evidence of the safety and efficacy of aztreonam for inhalation solution. ... Medical News Today (press release) European Stocks May Edge Higher - Dec 10, 2009 Drug maker Gilead Sciences, Inc. said the Anti-Infective Drugs Advisory Committee of the US Food and Drug Administration has recommended that aztreonam for ... RTT News New Inhaled Insulin, Provenge, Top List of 2010 Action Dates - Dec 31, 2009 ...based Gilead Sciences Inc.'s cystic fibrosis drug aztreonam. An advisory panel last month backed the drug, an aerosolized form of aztreonam lysine, ... BioWorld Online Cystic Fibrosis (CF) - Drug Pipeline Analysis and Market Forecasts to 2015 - Dec 22, 2009 Cayston (aztreonam lysine), Denufosol tetrasodium inhalation solution (INS37217), VX-770, Bronchitol and Ataluren (PTC-124) are the key products currently ... Online PR News (press release) Gilead blood pressure drug fails trial - Dec 15, 2009 Darusentan — like Gilead's inhaled antibiotic aztreonam lysine, which a Food and Drug Administration panel last week recommended as a cystic fibrosis ... Bizjournals.com Beratungsausschuss der FDA empfiehlt Einsatz von Aztreonam als ... - Dec 11, 2009 Der Ausschuss entschied mit 15 zu 2 Stimmen, dass Gilead genügend Nachweise zur Sicherheit und Wirksamkeit von Aztreonam als Inhalationslösung erbracht hat. ... Welt Online Salix, FDA discuss new drug application - Dec 11, 2009 Salix Pharmaceuticals said Friday it is on track to formally file a new drug application, or NDA, for its latest product in the first half of 2010. ... Bizjournals.com í?¡ìž…형 ë‚ì„±ì„¬ìœ ì¦? ì¹˜ë£Œì œ 美 승ì?¸ê¶Œê³ - Dec 13, 2009 ...길리어드ì?˜ í?¡ìž…형 í•ìƒ?ì œ 'ì¼€ì?´ìŠ¤í†¤'(Cayston, aztreonam)ì?´ 미êµì—?ì„œ í??ê°?ì—¼ ì¹˜ë£Œì œë¡œ 승ì?¸ê¶Œê³ 를 받았다. ë¯¸êµ FDA ìž?문위ì›?회는 ì¼€ì?´ìŠ¤í†¤ì—? 대해 ë‚ì„±ì„¬ìœ ì¦? 환ìž? ... 메디파나뉴스 ì§ˆë ˆë“œì‚¬ ë‚í?¬ì„± ì„¬ìœ ì¦? ë…¹ë†?ê· ì¹˜ë£Œì œ 허가 권장 - Dec 14, 2009 ...김윤ì˜? 기ìž? ë¯¸êµ FDA ìž?문위ì›?회는 ë‚í?¬ì„± ì„¬ìœ ì¦?(CF) 환ìž?ì?˜ ë…¹ë†?ê· (pseudomonas aeruginosa) ê°?ì—¼ 치료ì—? ì§ˆë ˆë“œ(Gilead)사ì?˜ ì•„ì¦ˆíŠ¸ë ˆì˜¤ë‚¨(aztreonam)í?¡ìž… ìš©ì•¡ì?„ ... 메디포뉴스 Politica farmaceutica - Dec 15, 2009 ...sollevato dubbi in merito all'analisi degli studi clinici presentati per dimostrare l'efficacia del farmaco sperimentale aztreonam di Gilead Sciences. ... Pharma Marketing Gilead Awaits Committee Outcome - Nov 13, 2009 The committee will review Gilead 's aztreonam for inhalation solution, an investigational product for the treatment of chronic pulmonary infections due to ... Zacks.com Gilead`sAztreonamforInhalationSolution to be Reviewed by FDA Anti-Infective ... - Oct 26, 2009 In September 2009, the product was granted conditional marketing approval in Canada and Europe under the trade name Cayston® (aztreonam lysine 75 mg powder ... Reuters Regulators question HGS drug; Gilead gets panel review date; - Oct 26, 2009 Story > Gilead Sciences says that aztreonam for inhalation solution, an investigational product for the treatment of infections due to Pseudomonas ... FierceBiotech FDA to review Gilead cystic fibrosis drug - Oct 26, 2009 The Foster City-based drug developer (NASDAQ: GILD) said that inhalable aztreonam lysine would be reviewed by the Food and Drug Administration's ... San Jose Business Journal Astellas and Theravance Announce Submission of Telavancin MAA for the ... - Oct 31, 2009 ...to the Gram-positive organisms for which study medication therapy was used, aztreonam, piperacillin-tazobactam, and/or metronidazole were allowed. ... PR-USA.net (press release) FDA将审查aztreonam上市申请 - Oct 26, 2009 ...(GILD) 43.83 : Gilead SCiencES宣布，美国FDA预定12月10日审查å?¸å…¥å¼?解决方案aztreonam，aztreonam治疗感染绿脓æ?†è?Œçš„病人。 å…?责声明：本文仅代表作者个人观点，与 ... 凤凰网 |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines The Cancer News Network
COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy |